These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 31324811)
1. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy. Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811 [TBL] [Abstract][Full Text] [Related]
2. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685 [TBL] [Abstract][Full Text] [Related]
3. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer. Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051 [TBL] [Abstract][Full Text] [Related]
4. Engineering Paclitaxel Prodrug Nanoparticles via Redox-Activatable Linkage and Effective Carriers for Enhanced Chemotherapy. Lu S; Xia R; Wang J; Pei Q; Xie Z; Jing X ACS Appl Mater Interfaces; 2021 Oct; 13(39):46291-46302. PubMed ID: 34558902 [TBL] [Abstract][Full Text] [Related]
5. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities. Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579 [TBL] [Abstract][Full Text] [Related]
6. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment. Liu T; Li L; Wang S; Dong F; Zuo S; Song J; Wang X; Lu Q; Wang H; Zhang H; Cheng M; Liu X; He Z; Sun B; Sun J Nat Commun; 2022 Nov; 13(1):7228. PubMed ID: 36434014 [TBL] [Abstract][Full Text] [Related]
7. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine. Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847 [TBL] [Abstract][Full Text] [Related]
8. Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment. Wang D; Huang Y; Yuan J; Wang S; Sheng J; Zhao Y; Zhang H; Wang X; Yu Y; Shi X; He Z; Liu T; Sun B; Sun J J Control Release; 2024 Nov; 375():47-59. PubMed ID: 39222794 [TBL] [Abstract][Full Text] [Related]
9. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety. Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247 [TBL] [Abstract][Full Text] [Related]
10. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity. Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644 [TBL] [Abstract][Full Text] [Related]
11. Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies. Wang D; Du C; Wang S; Li L; Liu T; Song J; He Z; Zhai Y; Sun B; Sun J ACS Appl Mater Interfaces; 2022 Nov; 14(45):51200-51211. PubMed ID: 36397309 [TBL] [Abstract][Full Text] [Related]
12. Probing the fluorination effect on the self-assembly characteristics, Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971 [No Abstract] [Full Text] [Related]
13. Carbon-Spaced Tandem-Disulfide Bond Bridge Design Addresses Limitations of Homodimer Prodrug Nanoassemblies: Enhancing Both Stability and Activatability. Zhang H; Liu T; Sun Y; Wang S; Wang W; Kuang Z; Duan M; Du T; Liu M; Wu L; Sun F; Sheng J; He Z; Sun J J Am Chem Soc; 2024 Aug; 146(32):22675-22688. PubMed ID: 39088029 [TBL] [Abstract][Full Text] [Related]
14. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy. Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896 [TBL] [Abstract][Full Text] [Related]
15. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
16. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy. Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178 [TBL] [Abstract][Full Text] [Related]
17. Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy. Yang J; Lv Q; Wei W; Yang Z; Dong J; Zhang R; Kan Q; He Z; Xu Y Drug Deliv; 2018 Nov; 25(1):807-814. PubMed ID: 29553858 [TBL] [Abstract][Full Text] [Related]
18. Satellite-Type Sulfur Atom Distribution in Trithiocarbonate Bond-Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability. Li L; Liu T; Zuo S; Li Y; Zhao E; Lu Q; Wang D; Sun Y; He Z; Sun B; Sun J Adv Mater; 2024 Jan; 36(4):e2310633. PubMed ID: 37983894 [TBL] [Abstract][Full Text] [Related]
19. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy. Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088 [TBL] [Abstract][Full Text] [Related]
20. Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a responsive module. Zhong W; Xu Y; Wang Z; Wang X; Li Y; Liu J; Zhao C; Shi X; He Z; Sun B; Tian C J Colloid Interface Sci; 2025 Jan; 678(Pt C):24-34. PubMed ID: 39277950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]